PNPLA3 and Hepatic fibrosis: We observed that the PNPLA3 I148M variant did not have any significant impact on clinical outcomes, progression of liver fibrosis, dominant stricture development, hepatobiliary cancer risk, the need for liver transplantation or patient survival.